In landmark studies based on gene expression profiling, Perou et al. and Sorlie et al. identified five molecular subtypes of breast cancer with distinctive clinical behavior and outcome: Luminal A, Luminal B, Her-2 enriched, Normal-like and Basal-like [5,6]. Here, ERBB2 is linked to breast cancer.